However, previous studies using IMR primarily investigated the presence or absence of CMD in only the left anterior descending coronary artery. Furthermore, little is known about Background-Difficulty directly visualizing the coronary microvasculature as opposed to the epicardial coronary artery makes its assessment challenging. The goal of this study is to measure the index of microcirculatory resistance (IMR) in all 3 major coronary vessels to identify the clinical and angiographic predictors of an abnormal IMR. Methods and Results-Ninety-three patients who underwent coronary physiological assessment in all 3 major coronary vessels were prospectively enrolled (59.8±9.4 years with 77.4% men). IMR was corrected using Yong's formula and coronary microvascular dysfunction (CMD) was defined using vessel-specific cutoffs. A global IMR was calculated as the sum of the IMR in all 3 major epicardial vessels. Angiographic epicardial disease severity was assessed with vessel-specific and overall SYNTAX score. Median IMR and fractional flow reserve was 17.2 (Q1-Q3: 13.3-22.9) and 0.92 (0.85-0.97). The majority of patients (59.1%) had no CMD, 23.7% had 1-vessel CMD, 14.0% had 2-vessel CMD, and 3.2% had 3-vessel CMD. CMD was observed at a similar rate in the territories supplied by all 3 major coronary vessels (left anterior descending coronary artery 28. whether clinical characteristics and epicardial coronary artery disease are predictive of the extent of microvascular dysfunction. Accordingly, the primary goal of the present study is to investigate the prevalence of CMD in the myocardial regions supplied by each of the 3 major coronary vessels by measuring IMR and to investigate the predictive value of clinical characteristics and epicardial coronary artery disease on the extent of CMD.
T he difficulty directly visualizing the coronary microvasculature, as opposed to the epicardial coronary vessels, has made the diagnosis of coronary microvascular dysfunction (CMD) in the catheterization laboratory challenging. The index of microcirculatory resistance (IMR) is a quantitative and reproducible measure of coronary microvascular function, readily applicable in the cardiac catheterization laboratory with a single pressure-temperature sensor guidewire. 1, 2 IMR has been increasingly applied to investigate the extent of CMD in various patient populations, such as those with ST-segment-elevation myocardial infarction, angina with or without obstructive coronary artery disease, and cardiac allograft vasculopathy after heart transplantation, establishing its role for assessing CMD in the cardiac catheterization laboratory. 3-Vessel IMR Investigation whether clinical characteristics and epicardial coronary artery disease are predictive of the extent of microvascular dysfunction. Accordingly, the primary goal of the present study is to investigate the prevalence of CMD in the myocardial regions supplied by each of the 3 major coronary vessels by measuring IMR and to investigate the predictive value of clinical characteristics and epicardial coronary artery disease on the extent of CMD.
Methods

Study Design and Patient Population
The 3V FFR-FRIENDS study (Three-Vessel Fractional Flow Reserve for the Assessment of Total Physiologic Atherosclerotic Burden and Its Clinical Impact in Patients With Coronary Artery Disease) is a multicenter, prospective, investigator-initiated observational study, assessing the 3-vessel coronary physiology in patients with clinical suspicion of ischemic heart disease. 10 In patients ≥18 years who underwent invasive physiological assessment of coronary artery lesions for standard clinical indications, comprehensive coronary physiological assessment including fractional flow reserve (FFR) and IMR was performed in 3 major epicardial coronary arteries.
Patients were excluded if they had previous coronary artery bypass surgery, an extremely tortuous or calcified coronary artery, known severe left ventricular hypertrophy, left ventricular ejection fraction <30%, inability to receive adenosine, or recent (within 3 weeks before cardiac catheterization) ST-segment-elevation myocardial infarction. This study was approved by an institutional review committee from each participating site, and informed consent was obtained from all patients. The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.
Coronary Angiography and Coronary Physiological Measurements
Coronary angiography was performed in a standard fashion. Angiographic views were obtained after the administration of intracoronary nitrate (100 or 200 μg). Quantitative coronary angiography (QCA) was performed at each participating center with a contour-detection QCA system. Parameters including percent diameter stenosis, minimum lumen diameter, reference vessel size, and lesion length were reported. 7 Invasive coronary physiological parameters were measured with a 0.014-inch pressure sensor guidewire and a console (PressureWire Certus or Aeris wire and the RadiAnalyzer console; then St. Jude Medical). After equalization to the guide catheter pressure with the sensor positioned at the ostium of the coronary artery, the pressure guidewire was advanced down the target coronary artery. With commercially available software, the shaft of the PressureWire can act as a proximal thermistor by detecting changes in temperature-dependent electric resistance. The sensor near the tip of the wire simultaneously measures pressure and temperature and can thereby act as a distal thermistor. The transit time of room-temperature saline injected down a coronary artery is then determined with a thermodilution technique. Approximately 3 mL of room temperature saline was injected rapidly by hand into the target coronary artery, and the resting mean transit time (T mn ) was obtained as an average of 3 injections. Thereafter, intravenous infusion of adenosine (140 μg/kg per minute) was administered to induce a steady state of maximal hyperemia, followed by 3 more injections of 3 mL of room temperature saline to calculate hyperemic T mn . Simultaneous measurements of mean proximal coronary pressure (P a , by guide catheter) and mean distal coronary pressure (P d , by PressureWire) were also acquired in the resting and maximal hyperemic status. FFR was calculated by the ratio of P d /P a at hyperemia. IMR was calculated as P d at hyperemia multiplied by hyperemic T mn . 1, 2 All IMR values were also corrected by Yong formula (IMR=P a ×T mn ×([1.35×P d /P a ] − 0.32)) to adjust for the influence of collateral flow. 11 At the end of the study, the guidewire was pulled back to the guiding catheter, and the presence of pressure drift was assessed to ensure appropriate recordings. If significant drift (>0.05) was detected, repeated measurement was recommended.
We used the vessel-specific IMR cutoff values to diagnose CMD. According to the previous publication by Lee et al, 7 the cutoff values for an abnormal IMR were defined as >22, 24, and 28 U for left anterior descending coronary artery (LAD), left circumflex artery (LCx), and right coronary artery (RCA), respectively. In their study, an abnormal IMR was defined as greater than the 75th percentile in each of the major coronary arteries. By using this method, the possible effect of left ventricular myocardial mass on IMR can be taken into account. 12 In the current study, in an attempt to quantify the extent of CMD, the global IMR was further defined as the sum of IMR measured in each of the 3 major coronary arteries. Because global IMR is the sum of IMR in all 3 myocardial territories and reflects the overall status of CMD, it is distinct from a vessel-specific IMR or a worst IMR among the 3 major coronary arteries.
Scoring Systems of Epicardial Coronary Artery Disease Status
Two representative scoring systems (SYNTAX score and Gensini score) were used to assess the severity of epicardial coronary artery disease. [13] [14] [15] These scores were obtained for patient level (overall coronary artery tree) and for vessel-specific level. The SYNTAX score was calculated from the preprocedural angiogram in which each coronary lesion producing ≥50% diameter stenosis in vessels ≥1.5 mm by visual estimation was scored separately using the SYNTAX score algorithm from the website and added to obtain the overall SYNTAX score. 13 Gensini 14, 15 score was calculated by taking severity of lesion narrowing, number of lesions, lesion location, and influence of collaterals into account.
End Points
The primary end point of this analysis was to assess the prevalence of CMD as determined by elevated IMR in each of the 3 major coronary arteries and to assess the correlation between epicardial coronary disease and CMD determined by IMR. As described above, epicardial disease status was assessed using SYNTAX score, Gensini score, FFR, and percent diameter stenosis by QCA. Comparisons were
WHAT IS KNOWN
• Difficulty directly visualizing the coronary microvasculature as opposed to the epicardial coronary artery makes its assessment challenging.
• The index of microcirculatory resistance is a quantitative and reproducible measure of coronary microvascular function, readily applicable in the cardiac catheterization laboratory.
WHAT THE STUDY ADDS
• By assessing the index of microcirculatory resistance in 3-vessel coronary territories, we found that the majority of patients (59.1%) had no coronary microvascular dysfunction (CMD), 23.7% had 1-vessel CMD, 14.0% had 2-vessel CMD, and 3.2% had 3-vessel CMD.
• The rate of CMD was similar in the territories subtended by the 3 major epicardial vessels. Clinical factors and epicardial coronary disease severity are not predictive of CMD, suggesting the importance of measuring the index of microcirculatory resistance when CMD is suspected. made on both a patient level and a vessel level if feasible. The secondary end point was to determine correlates of the extent of CMD among clinical, angiographic, and physiological information using univariable and multivariable ordinal regression models.
Statistical Analysis
Categorical variables are presented as counts and percentages. Pearson χ 2 test was used for comparisons of 2 sets of categorical variables. Continuous variables are presented as mean±SD or median (Q1-Q3), as appropriate. Two sets of continuous variables were compared with Mann-Whitney U test. Kruskal-Wallis test was used to assess the difference in IMR and FFR between institutions. Correlations between IMR and angiographic parameters were tested with Spearman correlation coefficient. Partial correlation accounting for the interrogated vessel was also performed between IMR and angiographic parameters. Logistic regression model was used to test whether the vessel territory is the independent predictor of the presence/absence of CMD after adjusting for patients' identification. Variables listed in Table I in the Data Supplement, SYNTAX score, Gensini score, and number of positive FFR vessel per patient were tested in univariable ordinal logistic regression analysis. Variables with P<0.25 in univariable ordinal logistic regression analysis were included in multivariable ordinal logistic regression model to determine an independent predictors of the extent of CMD. 16 By using ordinal regression analysis, the independent effect of variable on the severity of CMD (multiple outcome categories: no CMD, CMD in 1-vessel, CMD in 2-vessel, and CMD in 3-vessel territories) could be assessed. The proportional odds assumption was assessed for the ordinal regression model by using the test for parallel lines. A P value of <0.05 was considered statistically significant. All analyses were performed using SPSS version 21.
Results
A total of 93 patients and 279 vessels were included in this study from 4 Korean institutions. The patients' clinical, laboratory, and medication characteristics are summarized in Table 1 . The patients' angiographic and physiological characteristics are summarized in 
Prevalence of CMD
The number of vessels with CMD is shown in Figure 1A . The majority of patients (n=55, 59.1%) had no CMD, 22 patients (23.7%) had CMD in 1 vessel, 13 patients (14.0%) had CMD in 2 vessels, and 3 patients (3.2%) had CMD in all 3 vessels. The results were similar when the universal IMR cutoff of 25 was applied to all vessel territories. When the rate of CMD in each of the 3 vessels was compared between patients presenting with acute coronary syndrome and without, it was similar (P=0.56; Figure I in the Data Supplement). The prevalence of CMD in each vessel is shown in Figure 1B . The prevalence of CMD was similar between the 3 vessels (LAD versus LCx versus RCA: 28.0% versus 19.4% versus 23.7%; P=0.39). In the logistic regression model, the vessel territory (LAD, LCX, or RCA) was not the independent predictor of the presence/absence of CMD after adjusting for patients' identification.
Correlations Between Epicardial Disease Severity and CMD
The SYNTAX score had no significant correlation with IMR both at the patient level (ρ=−0. 39; B) . LAD indicates left anterior descending coronary artery; LCx, left circumflex artery; and RCA, right coronary artery. 3-Vessel IMR Investigation only hypercholesterolemia (odds ratio=0.35 [95% confidence interval, 0.14-0.91]; P=0.03) was left as an independent predictor of CMD, but the proportional odds assumption was not met for this model (P<0.01). When hypercholesterolemia was excluded from the multivariable model, no variable remained significant. Similarly, when high-density lipoprotein and lowdensity lipoprotein were excluded from the multivariable model, no variable remained significant.
Discussion
The principal finding of this study is that the majority of patients with a clinical suspicion of ischemic heart disease do not have CMD in any epicardial vessel. When they do have CMD, in most cases, it is localized to one vessel, with an equal chance between the 3 vessels. Furthermore, clinical characteristics typically correlated with epicardial coronary artery disease are not predictive of the extent of CMD, making it challenging to predict CMD. These results suggest the usefulness of measuring IMR in the cardiac catheterization laboratory when CMD is suspected.
Vergallo et al 17, 18 showed an association between the Framingham risk score/presentation/chronic kidney disease and high-risk coronary plaque characteristics as assessed by 3-vessel optical coherence tomography, demonstrating the actual link between the clinical profile and epicardial coronary artery disease status. On the contrary, in this study, the Framingham risk score did not predict the severity of CMD as assessed by IMR. Clinical and laboratory characteristics also were not predictive of CMD, although they are typically correlated with epicardial coronary artery disease development (note that in our model, the odds ratio of hypercholesterolemia was <1). These results may be because of the relatively small sample size of this study (279 vessels from 93 patients) and thereby weaker statistical power, compared with the report by Lee et al 7 (1452 vessels from 1092 patients), in which clinical characteristics such as history of myocardial infarction, sex, and high body mass index were predictive of elevated IMR. Or these results may be because of the different effect of clinical factors on the coronary microcirculation according to the distribution. Nevertheless, our results suggest that it would be challenging to predict CMD in a given patient using these clinical characteristics with C indexes of 0.67 (95% confidence interval, 0.64-0.70). 7 Furthermore, conventional noninvasive stress tests such as echocardiography and electrocardiography were shown to have no diagnostic value in identifying elevated IMR in patients presenting with angina and no obstructive coronary artery disease. 19 In the cardiac catheterization laboratory, the severity of epicardial coronary artery disease assessed by the coronary angiogram (SYNTAX score, Gensini score, and percent diameter stenosis by QCA) or invasive coronary physiology (FFR) is not collinear with the development of CMD as determined by IMR. Rather, FFR is weakly but positively correlated with IMR, suggesting that microvascular disease influences FFR by blunting the vasodilator response. Therefore, the presence of significant epicardial disease is not necessarily related to the presence of CMD. Taken together, the current study suggests the difficulty predicting the presence and the extent of CMD without actually measuring IMR. In the recent article by Lee et al 6 invasively investigating the left anterior descending coronary artery in patients with angina in the absence of obstructive coronary artery disease, 20% of patients were found to have CMD as determined by elevated IMR. Identifying the cause of chest pain in patients with no obstructive epicardial coronary artery disease is a typical scenario where interventional cardiologists may consider measuring IMR. 
3-Vessel IMR Investigation
There are some limitations to our study. First, as discussed above, the relatively small sample size of this study may have resulted in low statistical power. However, this study is the first to describe invasive assessment of coronary microcirculation in all 3 major coronary vessels in nearly 100 patients.
Second, because the enrolled patients primarily had a low SYNTAX score, the relationship between epicardial coronary artery disease and CMD in severe epicardial disease is not fully known. Third, because the IMR cutoff in each vessel is based on the IMR international registry that included patients 
96).
Fifth, it is possible that CMD overlaps territories supplied by 2 major coronary vessels and cannot be detected by evaluating vessel-specific IMR. Sixth, we did not collect angiographic data such as Duke Scores and Myocardial Jeopardy Index to account for the amount of subtended left ventricular mass. Finally, invasive coronary physiological assessments were performed at a single time point without clinical follow-up, and hence, we do not know the rate at which epicardial and microvascular disease progressed or the prognostic importance of the findings in this study.
Conclusions
Clinical characteristics typically associated with epicardial coronary artery disease development and the severity of epicardial coronary artery disease are not predictive of the extent of CMD. This may be particularly true in patients with angina who are referred to the cardiac catheterization laboratory but found to have no obstructive coronary artery disease.
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